Integrated Biopharma, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2020
November 12, 2020 at 09:23 pm
Share
Integrated BioPharma, Inc. announced earnings results for the first quarter ended September 30, 2020. For the first quarter, the company announced sales was USD 15.172 million compared to USD 11.406 million a year ago. Operating income was USD 1.509 million compared to USD 476,000 a year ago. Net income was USD 1.041 million compared to USD 312,000 a year ago. Basic earnings per share from continuing operations was USD 0.04 compared to USD 0.01 a year ago. Diluted earnings per share from continuing operations was USD 0.03 compared to USD 0.01 a year ago.
Integrated Biopharma Inc. is engaged primarily in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements, and herbal products. The Companyâs business segments include Contract Manufacturing operated by Manhattan Drug Company, Inc. (MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and specialized health-care providers; and Other Nutraceutical Businesses, which includes the operations of AgroLabs, Inc. (AgroLabs), The Vitamin Factory (the Vitamin Factory), IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. AgroLabs distributes healthful nutritional products for sale through mass market, grocery and drug and vitamin retailers under the brands: Peaceful Sleep, and Wheatgrass and other products. IHT is a distributor of fine natural botanicals, including multi-minerals produced under a license agreement. Chem is a distributor of raw materials.
INTEGRATED BIOPHARMA, INC. 